ArticleGalen medical journal2024
A Novel Persian Herbal Syrups: Preventive and Curative Effects of Syrup Formulation of Achillea. millefolium L. against Ethylene Glycol Induced Urolithiasis in Rats.
Article in Galen medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe urinary system is afflicted by urolithiasis, which stands as the third most common disabling disorder. The application of herbal plants is a widespread practice there is an increasing interest in research in this domain to establish scientific reasons for their beneficial properties. Hence, this study aimed to investigate the protective effects of the novel syrup formulations of Achillea millefolium against urolithiasis. MATERIALS AND
methodsThe two suspensions of A. millefolium, i.e., ethanolic and aqueous extracts were prepared. The 36 male Wistar rats were divided to six groups, i.e., group A (control), and ethylene glycol (EG) 1%-induced nephrolithiasis (groups B to F). The curative (C and D) and preventive (E and F) groups received 300 mg/kg body weight extracts orally from day 15 and first, respectively. After 28 days, the serum and urine samples, as well as, kidneys were taken for analysis and histopathologically for counting the calcium oxalate (CaOx) deposits, respectively.
resultsSerum parameters such as creatinine, blood urea nitrogen, and uric acid of group B rats were increased significantly in comparison to normal rats (P0.001) and extracts-treated groups (C to F). Also, our results indicated marked (P0.05) reductions in urinary oxalate, phosphate, and calcium in A. millefolium-treated rats; however, urine citrate in rats of group B was significantly reduced compared with other groups. Also, compared with group B, histopathological examinations revealed CaOx deposit reduction in groups C to F (P0.05).
conclusionResults of our study show that the treatment of rats with A. millefolium extracts had curative, as well as preventive properties on EG-induced kidney stones.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.